Visual Field Examination
J9 · Effective Oct 1, 2015
2 active Medicare policies list H35.3293, and 9 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J9 · Effective Oct 1, 2015
J9 · Effective Oct 1, 2025
9 policies from 2 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of H35.3293 |
|---|---|---|
| Age-Related Macular Degeneration | Feb 20, 2024 | Covered |
| Anecortave Acetate (Retaane) | Sep 20, 2023 | Covered |
| Brachytherapy | Jun 6, 2023 | Covered |
| Corneal Graft and Amniotic Membrane Transplantation, Corneal Stromal Lenticule Transplantation, Limbal Stem Cell Transplantation, or Sural Nerve Grafting for Ocular Indications | May 5, 2023 | Covered |
| Homocysteine Testing | Oct 26, 2023 | Covered |
| Laser Photocoagulation of Drusen | Sep 8, 2023 |
| Covered |
| Macular/Foveal Translocation | Jun 7, 2023 | Covered |
|---|
| Vascular Endothelial Growth Factor Inhibitors for Ocular Indications | Feb 20, 2024 | Covered |
|---|
| Policy | Effective | Status of H35.3293 |
|---|---|---|
| Implanted Port Delivery Systems to Treat Ocular Disease | Apr 15, 2026 | Not covered |